Forty U.S. students newly arrived in Mexico, twenty U.S. students who have been in Mexico for at least one year, and twenty Mexican students (all attending classes at Universidad Autonoma de Guadalajara) will be followed for diarrhea, asymptomatic infection by enteric pathogens, and development of serologic and coproantibody changes. Additionally, 100 students in each category (newly arrived U.S., established U.S., and Mexican) will be studied intensively during the months of January and August. We will assess difference in incidence of diarrhea due to seasonality, development of immunity, and role of intervening vacation in the U.S. on duration of immunity. Seven areas will be studied in this student population: 1) The natural history of diarrheal illness and enteric infection in U.S. adults establishing residence in Mexico. 2) The temporal acquisition of immunity and serum antibody development to organism-specific infection will be characterized. 3) The relationship of different enterotoxigenic E. coli occurring over time will be determined. 4) The secretory IgA response to ETEC infection will be studied. 5) The epidemiology of travelers' diarrhea will be studied. 6) The occurrence and cause of diarrhea, experienced when U.S. persons return home after living in Mexico, will be determined. 7) Populations for future vaccine studies will be sought. Figure 4 in the research plan presents a concise overview of the study design.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
5R01AI023049-04
Application #
3134931
Study Section
Epidemiology and Disease Control Subcommittee 3 (EDC)
Project Start
1986-04-01
Project End
1989-11-30
Budget Start
1989-04-01
Budget End
1989-11-30
Support Year
4
Fiscal Year
1989
Total Cost
Indirect Cost
Name
University of Texas Health Science Center Houston
Department
Type
Schools of Medicine
DUNS #
City
Houston
State
TX
Country
United States
Zip Code
77225
McNeely, W S; Dupont, H L; Mathewson, J J et al. (1996) Occult blood versus fecal leukocytes in the diagnosis of bacterial diarrhea: a study of U.S. travelers to Mexico and Mexican children. Am J Trop Med Hyg 55:430-3
DuPont, H L (1993) Travellers' diarrhoea. Which antimicrobial? Drugs 45:910-7
DuPont, H L; Ericsson, C D; Mathewson, J J et al. (1992) Five versus three days of ofloxacin therapy for traveler's diarrhea: a placebo-controlled study. Antimicrob Agents Chemother 36:87-91
DuPont, H L; Ericsson, C D; Mathewson, J J et al. (1992) Oral aztreonam, a poorly absorbed yet effective therapy for bacterial diarrhea in US travelers to Mexico. JAMA 267:1932-5
Bandres, J C; Mathewson, J J; Ericsson, C D et al. (1992) Trimethoprim/sulfamethoxazole remains active against enterotoxigenic Escherichia coli and Shigella species in Guadalajara, Mexico. Am J Med Sci 303:289-91
DuPont, H L (1991) Chemoprophylaxis remains an option in travelers' diarrhea. Am J Gastroenterol 86:403-4
DuPont, H L (1991) Use of quinolones in the treatment of gastrointestinal infections. Eur J Clin Microbiol Infect Dis 10:325-9
DuPont, H L (1991) Importance of collaborative research to improve world health. J Infect Dis 163:946-50
Vial, P A; Mathewson, J J; DuPont, H L et al. (1990) Comparison of two assay methods for patterns of adherence to HEp-2 cells of Escherichia coli from patients with diarrhea. J Clin Microbiol 28:882-5
DuPont, H L; Ericsson, C D; DuPont, M W et al. (1990) A randomized, open-label comparison of nonprescription loperamide and attapulgite in the symptomatic treatment of acute diarrhea. Am J Med 88:20S-23S

Showing the most recent 10 out of 20 publications